StockNews.com Begins Coverage on PEDEVCO (NYSE:PED)

StockNews.com started coverage on shares of PEDEVCO (NYSE:PED – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the stock. Separately, Alliance Global Partners started coverage on PEDEVCO in a research note on Wednesday, July 17th. They issued a buy rating and a $1.75 price […]

Leave a Reply

Your email address will not be published.

Previous post Trevi Therapeutics (NASDAQ:TRVI) Earns Outperform Rating from Analysts at Leerink Partners
Next post Reviewing Vivos Therapeutics (NASDAQ:VVOS) and Nemaura Medical (NASDAQ:NMRD)